A Randomized Controlled Trial to Improve Mother-Infant Synchrony Among Women With Childhood Adversity
1 other identifier
interventional
262
1 country
2
Brief Summary
Childhood adversity affects almost two-thirds of the US population, is a major risk factor for the leading causes of disease and increases US economic health burdens. Childhood adversity also alters biologic systems, such as the oxytocin hormone, that can affect attachment behavior. This innovative study has the potential to advance science and improve mother-infant interaction by testing an early life, home-based, multisensory behavioral intervention (called ATVV), targeting the oxytocin system, to promote synchronous early mother-infant interaction, especially critical for mothers who have experienced childhood adversity. This two-group randomized clinical trial will test the ATVV's effect on oxytocin system function and quality of mother-infant interaction. The investigators will enroll 250 first-time healthy mothers carrying a single baby who have a history of childhood adversity, and obtain baseline data in their third trimester of pregnancy. Soon after birth (before hospital discharge), mothers (and babies) who continue to be eligible are randomized into the intervention group and taught to give ATVV daily for 3 months, or randomized into the Attention Control education group and taught safe infant care. After birth, the investigators check-in frequently with mothers through weekly phone calls. There are 3 study visits at 1, 2 and 3 months after birth that include survey questions and collection of maternal blood and infant saliva. Mothers and babies are also video-recorded at 3 months after birth for 4 minutes to assess mother-infant interaction. The investigators follow-up with a phone call at 6 months after birth. While both groups will benefit from the content and attention the investigators give mothers, the investigators hypothesize that, compared to the education group, mothers and infants in the intervention group will have improved oxytocin system function and more synchronous mother-infant interaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2021
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2021
CompletedFirst Posted
Study publicly available on registry
March 26, 2021
CompletedStudy Start
First participant enrolled
July 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 17, 2024
CompletedResults Posted
Study results publicly available
August 13, 2025
CompletedAugust 13, 2025
July 1, 2025
2.7 years
March 23, 2021
April 30, 2025
July 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mother-Infant Synchrony, Gaze and Affect
Video-recordings of mothers freely interacting with their infant were micro-coded second by second for the number of seconds of mother-infant synchrony over 180 seconds. Behaviors are categorized into mutually exclusive codes. The most robust behavior categories for mothers and infants (individually and in synchrony) are gaze and affect. Maternal gaze consisted of mother's gaze to infant's face, to infant's body, to object or environment, and gaze aversion. Infant gaze consisted of gaze to mother, gaze to object or environment, and gaze aversion. Maternal affect consisted of positive, neutral, and negative affective expression. Infant affect consisted of high positive (laugh, giggle, smile), positive (smile, bright face), negative (sad face, occasional whimper), high negative (cry, strong whining), or neutral.
84 +/- 7days from birth (approximately 3 months after birth)
Secondary Outcomes (6)
Mother-Infant Synchrony, Vocalization and Touch
84 +/- 7days from birth (approximately 3 months after birth)
Oxytocin Receptor Gene DNA Methylation Reflecting Epigenetic Marks
Baseline at 31weeks +/- 2 weeks gestation and every 28 days +/- 7 days from birth to 3 months
Oxytocin Receptor Gene Expression
Baseline at 31weeks +/- 2 weeks gestation and every 28 days +/- 7 days from birth to 3 months
Oxytocin Receptor Protein
Baseline at 31weeks +/- 2 weeks gestation and every 28 days +/- 7 days from birth to 3 months
Oxytocin Peptide, Maternal Plasma
Baseline at 31weeks +/- 2 weeks gestation and every 28 days +/- 7 days from birth to 3 months
- +1 more secondary outcomes
Study Arms (2)
Behavioral ATVV intervention
EXPERIMENTALA multi-sensory behavioral intervention that includes auditory, tactile, visual and vestibular (ATVV) stimulation contingent upon infant cues.
Attention control
ACTIVE COMPARATORAn attention control group that receives education on safe infant care and the same amount of attention as the intervention group.
Interventions
A 15-minute behavioral intervention that mothers administer once daily to their infant for 3 months providing Auditory, Tactile, Visual, and Vestibular (ATVV) stimulation. Multisensory stimuli are presented in gradual progression. Mother-infant engagement is attempted throughout ATVV so that mothers learn to identify, interpret and adapt to their infants cues. ATVV can be given without eye to eye gaze making it appropriate for newborns. ATVV is offered contingent on infant cues to promote self-regulation and withdrawn if any persistent disengagement cues. Mothers are taught how to adapt ATVV as their infant grows. Fidelity to the intervention is checked with weekly phone calls and monthly study visits. Mothers also receive a daily text from REDCap to document an intervention frequency log.
Mothers in the Attention Control group receive a similar amount of daily texts, weekly phone call and in-person study visit attention as mothers in the ATVV group, but with distinctly different content. Over the first 3 postnatal months, mothers learn safe infant-care that includes content on diapers, infant clothing, blankets, infant care including bathing, sleep positions, sleep habits, holding the baby, safety of infant equipment, breastfeeding, formula, and age appropriate toys.
Eligibility Criteria
You may qualify if:
- Pregnant
- Healthy (gestational diabetes is acceptable)
- Greater than or equal to 18 years old
- Nulliparous (previous miscarriage(s) and/or abortion(s) acceptable)
- Speak and read English or Spanish
- Score greater than or equal to 2 on the Adverse Childhood Experience (ACE) survey
- Expect to deliver a healthy infant
- Expect to deliver a full-term infant (greater than or equal to 37 weeks and 0/7 days)
- Expect to deliver a singleton infant
You may not qualify if:
- Multiparous
- Have no access to a cell phone during the first 3 postnatal months
- Carrying multiple fetuses
- Taking anti-depressant(s) during pregnancy
- Taking illicit drugs
- Do not speak and read English or Spanish;
- Under 18 years of age
- Score less than 2 on the Adverse Childhood Experience (ACE) survey
- Deliver an infant diagnosed with conditions that could affect normal development or the oxytocin system
- Pre-term gestation (less than 37 weeks and 0/7 days)
- Intrauterine growth retardation (IGR)
- Small for gestational age (SGA)
- Chromosomal anomaly including
- Down syndrome (trisomy 21)
- Trisomy 13
- +11 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Arizonalead
- Children's Wisconsincollaborator
Study Sites (2)
Tucson Medical Center
Tucson, Arizona, 85712, United States
Banner University Medical Center - Tucson
Tucson, Arizona, 85719, United States
Related Publications (1)
Jones KA, Freijah I, Brennan SE, McKenzie JE, Bright TM, Fiolet R, Kamitsis I, Reid C, Davis E, Andrews S, Muzik M, Segal L, Herrman H, Chamberlain C. Interventions from pregnancy to two years after birth for parents experiencing complex post-traumatic stress disorder and/or with childhood experience of maltreatment. Cochrane Database Syst Rev. 2023 May 4;5(5):CD014874. doi: 10.1002/14651858.CD014874.pub2.
PMID: 37146219DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Aleeca Bell
- Organization
- University of Arizona
Study Officials
- PRINCIPAL INVESTIGATOR
Aleeca Bell, PhD
University of Arizona, College of Nursing
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The video coders measuring mother-infant synchrony will be blinded to group assignment.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 23, 2021
First Posted
March 26, 2021
Study Start
July 12, 2021
Primary Completion
March 8, 2024
Study Completion
June 17, 2024
Last Updated
August 13, 2025
Results First Posted
August 13, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share